Aim: To evaluate the prevalence of psychiatric comorbidity in migraine patients.
Materials and methods: A total of 60 patients diagnosed with migraine according to the International Classification of Headache Disorders (ICHD-3) were included in the study and were interviewed for depression and mental disorders according to ICD-10 criteria. The migraine disability assessment (MIDAS) questionnaire was used to understand the impact of headaches on patients’ lives and the disruption of daily activities.
Results: Migraine was more common in women, and while comorbid psychiatric disorders were detected in 42 patients (70%), dissociative disorder was the most common diagnosis (25%).
Conclusion: The incidence of psychiatric comorbidities is higher in migraine patients. Dissociative disorders are the most common psychiatric disorders, followed by depression.
Goadsby PJ. Migraine and other primary headache disorders. In: Jameson J, Fauci AS, Kasper DL, (Eds). Harrison's principles of internal medicine, 20th edition. McGraw Hill; 2018. Chapter: 422.
Amiri P, Kazeminasab S, Nejadghaderi SA, et al. Migraine: A review on its history, global epidemiology, risk factors, and comorbidities. Front Neurol 2022;12:800605. DOI: 10.3389/fneur.2021.800605.
Ashina M, Katsarava Z, Do TP, et al. Migraine: Epidemiology and systems of care. Lancet 2021;397(10283):1485–1495. DOI: 10.1016/S0140-6736(20)32160-7.
Saylor D, Steiner TJ. The global burden of headaches. Semin Neurol 2018;38(2):182–190. DOI: 10.1055/s-0038-1646946.
India state-level disease burden initiative neurological disorders collaborators. The burden of neurological disorders across the states of India: The global burden of disease study 1990–2019. Lancet Glob Health 2021;9(8):e1129–e1144. DOI: https://doi.org/10.1016/S2214-109X(21)00164-9.
GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: A systematic analysis for the global burden of disease study 2016. Lancet Neurol 2018;17(11):954–976. DOI: 10.1016/S1474-4422(18)30322-3.
Lipton RB, Bigal ME, Diamond M, et al. AMPP advisory group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68(5):343–349. DOI: 10.1212/01.wnl.0000252808.97649.21.
Ravishankar K. Migraine management in developing countries: Barriers to care—a headache clinic study from India. Cephalalgia 2003;23:577. PMID: 15324725.
Steiner TJ, Stovner LJ, Katsarava Z, et al. The impact of headache in Europe: Principal results of the Eurolight project. J Headache Pain 2014;15(1):31. DOI: 10.1186/1129-2377-15-31.
Buse DC, Reed ML, Fanning KM, et al. Comorbid and co-occurring conditions in migraine and associated risk of increasing headache pain intensity and headache frequency: Results of the migraine in America symptoms and treatment (MAST) study. J Headache Pain 2020;21(1):23. DOI: 10.1186/s10194-020-1084-y.
Lemmens J, De Pauw J, Van Soom T, et al. The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: A systematic literature review and meta-analysis. J Headache Pain 2019;20(1):16. DOI: 10.1186/s10194-019-0961-8.
Peterlin BL, Katsnelson MJ, Calhoun AH. The associations between migraine, unipolar psychiatric comorbidities, and stress-related disorders and the role of estrogen. Curr Pain Headache Rep 2009;13(5):404–412. DOI: 10.1007/s11916-009-0066-1.
Kori P, Ramdurg S. Prevalence of mental health problems in migraine patients: A hospital-based study. JMR 2020;6(5):212–215. DOI: 10.31254/jmr.2020.6508.
Bhatia MS, Gupta R. Migraine: Clinical pattern and psychiatric comorbidity. Ind Psychiatry J 2012;21(1):18–21. DOI: 10.4103/0972-6748.110943.
Ismail H, Fayaz F. Psychiatric comorbidity in patients with migraine. Int J Adv Med 2022;9(9):924–927. DOI: https://dx.doi.org/10.18203/2349-3933.ijam20222098.
